These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 30335787)
1. cGMP production of astatine-211-labeled anti-CD45 antibodies for use in allogeneic hematopoietic cell transplantation for treatment of advanced hematopoietic malignancies. Li Y; Hamlin DK; Chyan MK; Wong R; Dorman EF; Emery RC; Woodle DR; Manger RL; Nartea M; Kenoyer AL; Orozco JJ; Green DJ; Press OW; Storb R; Sandmaier BM; Wilbur DS PLoS One; 2018; 13(10):e0205135. PubMed ID: 30335787 [TBL] [Abstract][Full Text] [Related]
2. Durable donor engraftment after radioimmunotherapy using α-emitter astatine-211-labeled anti-CD45 antibody for conditioning in allogeneic hematopoietic cell transplantation. Chen Y; Kornblit B; Hamlin DK; Sale GE; Santos EB; Wilbur DS; Storer BE; Storb R; Sandmaier BM Blood; 2012 Feb; 119(5):1130-8. PubMed ID: 22134165 [TBL] [Abstract][Full Text] [Related]
3. Reagents for astatination of biomolecules. 4. Comparison of maleimido-closo-decaborate(2-) and meta-[(211)At]astatobenzoate conjugates for labeling anti-CD45 antibodies with [(211)At]astatine. Wilbur DS; Thakar MS; Hamlin DK; Santos EB; Chyan MK; Nakamae H; Pagel JM; Press OW; Sandmaier BM Bioconjug Chem; 2009 Oct; 20(10):1983-91. PubMed ID: 19731929 [TBL] [Abstract][Full Text] [Related]
4. Reagents for astatination of biomolecules. 2. Conjugation of anionic boron cage pendant groups to a protein provides a method for direct labeling that is stable to in vivo deastatination. Wilbur DS; Chyan MK; Hamlin DK; Vessella RL; Wedge TJ; Hawthorne MF Bioconjug Chem; 2007; 18(4):1226-40. PubMed ID: 17583925 [TBL] [Abstract][Full Text] [Related]
5. Development of a preclinical Crawford JR; Yang H; Kunz P; Wilbur DS; Schaffer P; Ruth TJ Nucl Med Biol; 2017 May; 48():31-35. PubMed ID: 28193502 [TBL] [Abstract][Full Text] [Related]
6. Reagents for astatination of biomolecules. 6. An intact antibody conjugated with a maleimido-closo-decaborate(2-) reagent via sulfhydryl groups had considerably higher kidney concentrations than the same antibody conjugated with an isothiocyanato-closo-decaborate(2-) reagent via lysine amines. Wilbur DS; Chyan MK; Nakamae H; Chen Y; Hamlin DK; Santos EB; Kornblit BT; Sandmaier BM Bioconjug Chem; 2012 Mar; 23(3):409-20. PubMed ID: 22296587 [TBL] [Abstract][Full Text] [Related]
14. [Investigator-Initiated Clinical Trial of 211At-NaAt against Refractory Thyroid Cancer]. Watabe T Gan To Kagaku Ryoho; 2022 Aug; 49(8):829-834. PubMed ID: 36046965 [TBL] [Abstract][Full Text] [Related]
15. Labeling monoclonal antibodies and F(ab')2 fragments with the alpha-particle-emitting nuclide astatine-211: preservation of immunoreactivity and in vivo localizing capacity. Zalutsky MR; Garg PK; Friedman HS; Bigner DD Proc Natl Acad Sci U S A; 1989 Sep; 86(18):7149-53. PubMed ID: 2476813 [TBL] [Abstract][Full Text] [Related]
17. Preparation of 211At-labeled humanized anti-Tac using 211At produced in disposable internal and external bismuth targets. Schwarz UP; Plascjak P; Beitzel MP; Gansow OA; Eckelman WC; Waldmann TA Nucl Med Biol; 1998 Feb; 25(2):89-93. PubMed ID: 9468021 [TBL] [Abstract][Full Text] [Related]
18. Optimisation of cyclotron production parameters for the 209Bi(alpha, 2n) 211At reaction related to biomedical use of 211At. Henriksen G; Messelt S; Olsen E; Larsen RH Appl Radiat Isot; 2001 May; 54(5):839-44. PubMed ID: 11258534 [TBL] [Abstract][Full Text] [Related]
19. Construction and Preclinical Evaluation of 211At Labeled Anti-mesothelin Antibodies as Potential Targeted Alpha Therapy Drugs. Wang X; Ma W; Liu W; Ma H; Yang Y; Wang Y; Liu N; Yang G J Radiat Res; 2020 Sep; 61(5):684-690. PubMed ID: 32648573 [TBL] [Abstract][Full Text] [Related]
20. Radioimmunotherapy with bismuth-213 as conditioning for nonmyeloablative allogeneic hematopoietic cell transplantation in dogs: a dose deescalation study. Bethge WA; Wilbur DS; Storb R; Hamlin DK; Santos EB; Brechbiel MW; Sandmaier BM Transplantation; 2004 Aug; 78(3):352-9. PubMed ID: 15316362 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]